Abstract:Objective— Thioredoxin-2 (Trx2), a major antioxidant protein in mitochondria, enhances nitric oxide bioavailability and inhibits ASK1-dependent apoptosis in endothelial cells (ECs). However, the in vivo role of Trx2 in angiogenesis has not been defined. Here we used EC-specific transgenesis of Trx2 (Trx2-TG) in mice to determine the in vivo function of Trx2 in arteriogenesis and angiogenesis. Methods and Results— In a femoral artery ligation model, Trx2-TG mice had enhanced capacity in limb perfusion recovery and ischemic reserve capacity compared to the nontransgenic littermates. Ischemia-initiated arteriogenesis in the upper limb was augmented in Trx2-TG mice. Trx2-TG mice also showed significantly enhanced capillary formation and maturation in the lower limb. In nontransgenic limb, ischemia specifically induced a downregulation of Trx2 protein, leading to increased oxidative stress, ASK1 activation, and EC apoptosis. In contrast, Trx2-TG maintained a constitutive level of Trx2, reducing the ischemia-induced deleterious responses. We then defined the mechanism by which Trx2 increases angiogenesis using ECs isolated from Trx2-TG mice. Trx2-TG ECs showed increased NO and NO-dependent migration. In addition, these cells were more resistant to oxidative stress–induced activation of ASK1 signaling and apoptosis. Moreover, Trx2-augmented EC survival is NO-independent. To define the relative contributions of Trx2-increased NO and Trx2-reduced ASK1 apoptotic activity to angiogenesis in vivo, we examined Trx2 effects on ischemia-induced angiogenesis in eNOS-deficient mice. The eNOS deletion caused severe impairment in the functional flow recovery in response to ischemia. Trx2 expression in eNOS-KO mice still dramatically inhibited ischemia-induced ASK1 and EC apoptosis, leading to an enhanced functional flow recovery. Conclusion— These in vivo and in vitro data support that Trx2 maintains EC function by two parallel pathways—scavenging ROS to increase NO bioavailability and inhibiting ASK1 activity to enhance EC survival, facilitating ischemia-mediated arteriogenesis and angiogenesis.

Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production

Abstract 178: Angiogenesis is Triggered by Nutrient Deprivation via Gcn2/atf4-dependent Regulation of Vegf and H2s Production

Endothelial-Specific Expression of Mitochondrial Thioredoxin Promotes Ischemia-Mediated Arteriogenesis and Angiogenesis

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide-Mediated Angiogenesis

Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis

H2S is a Promoter of Angiogenesis: Identification of H2S "receptors" and Its Molecular Switches in Vascular Endothelial Cells.

Sulfide oxidation promotes hypoxic angiogenesis and neovascularization

Hydrogen sulfide promotes angiogenesis 1 by down-regulating miR-640 2 via the VEGFR 2 / mTOR pathway 3 4

Vascular Endothelial Growth Factor Signaling Requires Glycine to Promote Angiogenesis

S-Glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration

Role of hydrogen sulphide in physiological and pathological angiogenesis

Endothelial Drp1 Couples VEGF-induced Redox Signaling with Glycolysis Through Cysteine Oxidation to Drive Angiogenesis

Hypoxia-inducible factor-1α is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress.

Endothelial Cell Redox Regulation of Ischemic Angiogenesis

Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves Mtor Malonylation.

Cystathionine Gamma-Lyase Regulates Arteriogenesis Through No-Dependent Monocyte Recruitment

Mechanisms of Angiogenesis: Role of Hydrogen Sulphide

OP29 Identification of the Molecular Switch and the Receptor for H2S to Promote Angiogenesis

Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.

Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8

Endothelial G protein stimulatory alpha-subunit is a critical regulator of post-ischemic angiogenesis